DCF — TEXAS HEALTH KAUFMAN
Enterprise Value: $50.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$50.4M
Enterprise Value
$13.7M
PV of Cash Flows
$36.7M
PV of Terminal Value
$59.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $46.2M | $6.1M | 13.0% | $2.9M | $2.6M |
| Year 2 | $47.6M | $6.7M | 14.0% | $3.3M | $2.8M |
| Year 3 | $49.0M | $7.4M | 15.0% | $3.8M | $2.9M |
| Year 4 | $50.5M | $7.9M | 16.0% | $4.1M | $2.8M |
| Year 5 | $52.0M | $8.3M | 16.0% | $4.3M | $2.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $50.4M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$44.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.12641711304368927
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5